Mackenzie Financial Corp Regeneron Pharmaceuticals, Inc. Transaction History

Mackenzie Financial Corp

$66.8 Billion
Q3 2024

A detailed history of Mackenzie Financial Corp transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Mackenzie Financial Corp holds 55,992 shares of REGN stock, worth $42.2 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

55,992

Previous 57,964 3.4%

Holding current value

$42.2 Million

Previous $60.9 Million 3.38%

% of portfolio

0.09%

Previous 0.1%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$1024.09 - $1201.76 $2.02 Million - $2.37 Million	-1,972 Reduced 3.4%	55,992 $58.9 Million
Q2 2024 Aug 14, 2024	BUY	$883.2 - $1071.19 $1.83 Million - $2.22 Million	2,074 Added 3.71%	57,964 $60.9 Million
Q1 2024 May 10, 2024	SELL	$902.69 - $993.35 $356,562 - $392,373	-395 Reduced 0.7%	55,890 $53.8 Million
Q4 2023 Jan 30, 2024	SELL	$775.18 - $881.7 $47,285 - $53,783	-61 Reduced 0.11%	56,285 $49.4 Million
Q3 2023 Oct 25, 2023	SELL	$692.45 - $844.37 $2.28 Million - $2.78 Million	-3,298 Reduced 5.53%	56,346 $46.4 Million
Q2 2023 Aug 03, 2023	SELL	$700.03 - $830.35 $4.95 Million - $5.87 Million	-7,066 Reduced 10.59%	59,644 $42.9 Million
Q1 2023 Apr 24, 2023	SELL	$680.49 - $826.97 $3.57 Million - $4.33 Million	-5,239 Reduced 7.28%	66,710 $54.8 Million
Q4 2022 Feb 14, 2023	SELL	$705.89 - $766.39 $6.91 Million - $7.5 Million	-9,787 Reduced 11.97%	71,949 $51.9 Million
Q3 2022 Oct 07, 2022	SELL	$573.97 - $724.32 $4.31 Million - $5.44 Million	-7,512 Reduced 8.42%	81,736 $56.3 Million
Q2 2022 Aug 10, 2022	SELL	$548.35 - $738.84 $2.56 Million - $3.44 Million	-4,662 Reduced 4.96%	89,248 $52.8 Million
Q1 2022 May 13, 2022	BUY	$595.12 - $698.43 $3.39 Million - $3.98 Million	5,702 Added 6.46%	93,910 $65.6 Million
Q4 2021 Feb 14, 2022	SELL	$543.48 - $670.97 $196,739 - $242,891	-362 Reduced 0.41%	88,208 $55.7 Million
Q3 2021 Nov 08, 2021	BUY	$574.03 - $680.96 $68,309 - $81,034	119 Added 0.13%	88,570 $53.6 Million
Q2 2021 Aug 11, 2021	BUY	$472.8 - $558.54 $8.64 Million - $10.2 Million	18,282 Added 26.05%	88,451 $49.4 Million
Q1 2021 May 14, 2021	BUY	$446.73 - $548.2 $14.9 Million - $18.3 Million	33,297 Added 90.3%	70,169 $33.2 Million
Q4 2020 Feb 10, 2021	BUY	$478.3 - $607.98 $2.61 Million - $3.32 Million	5,465 Added 17.4%	36,872 $17.8 Million
Q3 2020 Nov 13, 2020	BUY	$544.75 - $658.21 $4.43 Million - $5.35 Million	8,125 Added 34.9%	31,407 $17.6 Million
Q2 2020 Aug 13, 2020	BUY	$493.32 - $643.92 $2.23 Million - $2.91 Million	4,521 Added 24.1%	23,282 $14.5 Million
Q1 2020 May 14, 2020	BUY	$336.18 - $494.43 $199,354 - $293,196	593 Added 3.26%	18,761 $9.16 Million
Q4 2019 Feb 13, 2020	BUY	$274.13 - $376.51 $4.04 Million - $5.54 Million	14,722 Added 427.22%	18,168 $6.82 Million
Q3 2019 Nov 14, 2019	BUY	$273.46 - $318.39 $679,548 - $791,199	2,485 Added 258.58%	3,446 $956,000
Q2 2019 Aug 14, 2019	SELL	$299.6 - $414.82 $1.75 Million - $2.43 Million	-5,851 Reduced 85.89%	961 $301,000
Q1 2019 May 15, 2019	BUY	$372.08 - $439.57 $1.98 Million - $2.33 Million	5,308 Added 352.93%	6,812 $2.8 Million
Q4 2018 Feb 06, 2019	SELL	$335.82 - $403.04 $1,343 - $1,612	-4 Reduced 0.27%	1,504 $562,000
Q3 2018 Nov 15, 2018	BUY	$351.14 - $408.51 $79,006 - $91,914	225 Added 17.54%	1,508 $609,000
Q2 2018 Aug 13, 2018	BUY	$284.6 - $344.99 $77,126 - $93,492	271 Added 26.78%	1,283 $443,000
Q1 2018 May 14, 2018	BUY	$315.82 - $393.78 $148,119 - $184,682	469 Added 86.37%	1,012 $348,000
Q4 2017 Feb 13, 2018	BUY	$358.63 - $469.95 $194,736 - $255,182	543	543 $204,000

Others Institutions Holding REGN

# of Institutions

1,532

Shares Held

84.1M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $80.7B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mackenzie Financial Corp with notifications on news.

Account

Mackenzie Financial Corp Regeneron Pharmaceuticals, Inc. Transaction History